IASLC – International Association for the Study of Lung Cancer
ESMO – European Association of Medical Oncology
ERS – European Respiratory Society
UMOS – Udruženje medilkalnih onkologa Srbije
SLD – Srpsko Lekarsko Društvo, Sekcija za palijativnu medicinu (predsednik sekcije), Reginalna lekarska komora Vojvodine
UBS – Udruženje bronhologa Srbije
RUS – Respiratorno Udruženje Srbije

Zaric B, Djekic Malbasa J, Kovacevic T, Simurdic P, Stojšić V, Stojanovic G. Independent Predictors Associated with Patient Refusal of Invasive Diagnostic Procedures After Positive LDCT Lung Cancer Screening. Diagnostics. 2026; 16(5):709. https://doi.org/10.3390/diagnostics16050709

Zaric B, Perin B, Becker HD, Herth FJF, Eberhardt R, Djuric M, Djuric D, Matijasevic J, Kopitovic I, Stanic J. Autofluorescence imaging (AFI) videobronchoscopy in detection of lung cancer: from research tool to everyday procedure. Expert Rev Med Devices 2011; 8 (2): 167-172.

Zaric B, Stojcevic J, Andrijevic LJ, Andrijevic I, Kuruc V, Veselinovic I, Salatic I. Relation of functional characteristics and serum alpha-1-antitripsin (AAT) concentration in patients with PiMM phenotype and chronic obstructive pulmonary disease (COPD). Eur J Intern Med 2011; 22 (6): 603-606.

Zaric B, Stojsic V, Kovacevic T, Sarcev T, Tepavac A, Jankovic R, Spasic J, Radosavljevic D, Zarogoulidis P, Vukobradovic-Djoric N, Perin B. Clinical characteristics, tumor, node, metastasis status, and mutation rate in domain of epidermal growth factor receptor gene in serbian patients with lung adenocarcinoma. J Thorac Oncol. 2014;9(9):1406-10

Zaric B, Kovacevic T, Stojsic V, Sarcev T, Kocic M, Urosevic M, Kalem D, Perin B. Neodymium yttrium-aluminium-garnet laser resection significantly improves quality of life in patients with malignant central airway obstruction due to lung cancer. Eur J Cancer Care 2015; 24(4):560-6.

Ramalingam S, Goss G, Rosell R, Schmid-Bindert G, Zaric B, Andric Z, et al. A randomized phase II study of ganetespib, a heat shock protein 90 inhibitor, in combination with docetaxel in second-line therapy of advanced non-small cell lung cancer (GALAXY-1). Ann Oncol. 2015; 26(8):1741-8.

Zaric B, Brcic L, Buder A, Brandstetter A, Buresch JO, Traint S, Kovacevic T, Stojsic V, Perin B, Pirker R, Filipits M. PD-1 and PD-L1 Protein Expression Predict Survival in Completely Resected Lung Adenocarcinoma. Clin Lung Cancer. 2018;19(6):e957-e963.

Zaric B, Stojsic V, Panjkovic M, et al. Clinicopathological features and relation between anaplastic lymphoma kinase (ALK) mutation and histological subtype of lung adenocarcinoma in Eastern European Caucasian population. J Cancer. 2016; 7(15):2207-2212

Djekic Malbas J, Kovacevic T, Vukoja M, Bursac D, Bokan D, Stojsic V, Zaric B. Nodule Characteristics, Clinical Risk Factors, and Radiologist Experience as Predictors of Positive Baseline LDCT Screening Results. Healthcare. 2025;13(21):2734

Donker EM, Timpone PS, Brinkman DJ, Richir MC, Papaioannidou P, Likić R, Horvat O, Rašković A, Stilinović N, Jeremić D, Ilić M, Kovačević T, Halgato T, Rapajić M, Milak A.The European List of Key Medicines for Medical Education: A Modified Delphi Study. Clinical Pharmacology and Therapeutics. 2024;115(3):515-24

Kovačević T, Zarić B, Đekić-Malbaša J, Bokan D, Nikolin B, Bursać D, Simurdić P, Stojšić V, Stojanović G, Marić D. Attitudes toward Death among Health Care Professionals in the Balkan Region. Current Oncology. 2024;31(6)3350-60

Đekić-Malbaša J, Kovačević T, Zarić B, Dugandžija T, Nikolin B, Radovanović D, Paut-Kusturica M. Decade of lung cancer in Serbia: tobacco abuse and gender differences. EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES. 2023;27(7):3105-16

Alvarez-Romero C, Martinez-Garcia A, Ternero Vega J, Díaz-Jimènez P, Jimènez-Juan C, Nieto-Martín MD, Román Villarán E, Kovacevic T, Bokan D, Hromis S, Djekic Malbasa J, Beslać S, Zaric B, Gencturk M, Sinaci AA, Ollero Baturone M, Parra Calderón CL. Predicting 30-Day Readmission Risk for Patients With Chronic Obstructive Pulmonary Disease Through a Federated Machine Learning Architecture on Findable, Accessible, Interoperable, and Reusable (FAIR) Data: Development and Validation Study. JMIR MEDICAL INFORMATICS. 2022;10(6):e35307

Spasic J, Cavic M, Stanic N, Zaric B, Kovacevic T, Radosavljevic D, Nagorni-Obradovic L. Low-Cost Genetic and Clinical Predictors of Response and Toxicity of Platinum-Based Chemotherapy in Advanced Non-Small Cell Lung Cancer. Dose Response. 2022 Jun 28;20(2):15593258221111666.

Cavic M, Kovacevic T, Zaric B, Stojiljkovic D, Jovanovic Korda N, Rancic M, Jankovic R, RadosavljevicD, Stojanovic G, Spasic J. Lung Cancer in Serbia. JTO. 2022;17(7):867-72

Bursac D, Zaric B, Bokan D, Kovacevic T, Stojsic V, Petkov S, Mitrovic K, Stojanovic G. Mortality of COVID-19 pneumonia during anticancer treatment in lung cancer patients. Vojnosanitetski pregled. 2022;79(5):18

Zarogoulidis P, Christakidis V, Petridis D, Sapalidis K, Kosmidis C, Vagionas A, Perdikouri EI, Hohenforst-Schmidt W, Huang H, Petanidis S, Tsakiridis K, Baka S, Romanidis K, Zaric B, Kovacevic T, Stojsic V, Sarcev T, Bursac D, Kukic B, Boukovinas I, Tolis C, Sardeli C. Connection between PD-L1 expression and standardized uptake value in NSCLC: an early prognostic treatment combination. Expert Rev Respir Med. 2021;15(5):675-679.

Zarogoulidis P, Huang H, Zhou J, Ning Y, Yang M, Wang J, Zhang R, Bai C, Shen X, Huang Z, Petridis D, Kosmidis C, Kosmidou M, Tsakiridis K, Hohenforst-Schmidt W, Baka S, Petanidis S, Zaric B, Kovacevic T, Stojsic V, Sarcev T, Bursac D, Kukic B, Rapti A, Pantea S, Rogoveanu O, Rogoveanu I, Romanidis K, Kesisoglou I, Ioannidis A, Vagionas A, Sapalidis K. Thyroid cancer diagnosis with transdermal probe 22G U/S versus EBUS-convex probe TBNA-B 22G and 19G: pros and cons. Expert Rev Med Devices. 2021;18(2):197-201.